Hydroxyzine
Brand names: HYDROXYZINE HCL, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE PAMOATE, HydrOXYzine Hydrochloride, HydrOXYzine hydrochloride, Hydroxyzine Hydrochloride, Hydroxyzine Pamoate, Hydroxyzine hydrochloride, Hydroxyzine pamoate, Vistaril, hydroxyzine hydrochloride, hydroxyzine pamoate, Hydroxyzine
Warnings
No boxed warning. Hydroxyzine is contraindicated in patients with known hypersensitivity to hydroxyzine or to cetirizine/levocetirizine, in patients with "a prolonged QT interval," and is "contraindicated in early pregnancy"; it should not be given to nursing mothers. The label warns that hydroxyzine "has been associated with QT interval prolongation and Torsade de Pointes," a risk increased by concomitant use of other QT-prolonging drugs, and that it potentiates the CNS-depressant effects of narcotics, non-narcotic analgesics, barbiturates, and other CNS depressants.
Contraindications
CONTRAINDICATIONS Oral hydroxyzine hydrochloride is contraindicated in patients with known hypersensitivity to hydroxyzine hydrochloride products, and in patients with known hypersensitivity to cetirizine hydrochloride or levocetirizine hydrochloride. Hydroxyzine is contraindicated in patients with a prolonged QT interval. Hydroxyzine, when administered to the pregnant mouse, rat and rabbit induced fetal abnormalities in the rat and mouse at doses substantially above the human therapeutic range. Clinical data in human beings are inadequate to establish safety in early pregnancy. Until such data are available, hydroxyzine is contraindicated in early pregnancy. Hydroxyzine is contraindicated for patients who have shown a previous hypersensitivity to it.
Overdose
OVERDOSAGE The most common manifestation of hydroxyzine overdosage is hypersedation. As in the management of overdosage with any drug, it should be borne in mind that multiple agents may have been taken. If vomiting has not occurred spontaneously, it should be induced. Immediate gastric lavage is also recommended. General supportive care, including frequent monitoring of the vital signs and close observation of the patient, is indicated. Hypotension, though unlikely, may be controlled with intravenous fluids and levarterenol or metaraminol. Do not use epinephrine as hydroxyzine counteracts its pressor action. Hydroxyzine overdose may cause QT prolongation and Torsade de Pointes. ECG monitoring is recommended in cases of hydroxyzine overdose. There is no specific antidote. It is doubtful that hemodialysis would be of any value in the treatment of overdosage with hydroxyzine. However, if other agents such as barbiturates have been ingested concomitantly, hemodialysis may be indicated. There is no practical method to quantitate hydroxyzine in body fluids or tissue after its ingestion or administration.
Uses
Hydroxyzine Hydrochloride Tablets are indicated for: - Symptomatic relief of "anxiety and tension associated with psychoneurosis" and as adjunctive therapy in organic disease states where anxiety is a component - "Management of pruritus due to allergic conditions such as chronic urticaria and atopic and contact dermatoses" - As a sedative when used as a premedicant and following general anesthesia
Dosage forms & strengths
DOSAGE AND ADMINISTRATION For symptomatic relief of anxiety and tension associated with psychoneurosis and as an adjunct in organic disease states in which anxiety is manifested: Adults, 50 to 100 mg q.i.d.; children under 6 years, 50 mg daily in divided doses; children over 6 years, 50 to 100 mg daily in divided doses. For use in the management of pruritus due to allergic conditions such as chronic urticaria and atopic and contact dermatoses and in histamine-mediated pruritus: adults, 25 mg t.i.d. or q.i.d.; children under 6 years, 50 mg daily in divided doses; children over 6 years, 50 to 100 mg daily in divided doses. As a sedative when used as a premedication and following general anesthesia: 50 to 100 mg for adults and 0.6 mg/kg of body weight in children. When treatment is initiated by the intramuscular route of administration, subsequent doses may be administered orally. As with all potent medication, the dosage should be adjusted according to the patient's response to therapy.
All identified pills
112 N
WHITE ROUND · Hydroxyzine
4 manufacturers
113
WHITE ROUND · Hydroxyzine
114
WHITE ROUND · Hydroxyzine
3615 V
ORANGE ROUND · Hydroxyzine
2 manufacturers
3616 V
GREEN ROUND · Hydroxyzine
6 manufacturers
3617 V
ORANGE ROUND · Hydroxyzine
4 manufacturers
71 AN
WHITE ROUND · Hydroxyzine
75 A
WHITE ROUND · Hydroxyzine
A 75
WHITE ROUND · Hydroxyzine
3 manufacturers
AN 71
WHITE ROUND · Hydroxyzine
8 manufacturers
AN 77
WHITE ROUND · Hydroxyzine
5 manufacturers
DAN 5726
GREEN CAPSULE · Hydroxyzine
DAN 5522
ORANGE ROUND · Hydroxyzine
DAN 5523
GREEN ROUND · Hydroxyzine
2 manufacturers
DAN 5565
YELLOW ROUND · Hydroxyzine
Debossed K11
WHITE ROUND · Hydroxyzine
E 613
GREEN CAPSULE · Hydroxyzine
E 615
GREEN CAPSULE · Hydroxyzine
E159
ORANGE ROUND · Hydroxyzine
5 manufacturers
E160
GREEN ROUND · Hydroxyzine
12 manufacturers
E161
YELLOW ROUND · Hydroxyzine
5 manufacturers
E613
GREEN CAPSULE · Hydroxyzine
E613
GREEN CAPSULE · Hydroxyzine
29 manufacturers
E615
GREEN CAPSULE · Hydroxyzine
21 manufacturers
E615
GREEN;WHITE CAPSULE · Hydroxyzine
EP112
GREEN;WHITE CAPSULE · Hydroxyzine
14 manufacturers
EP112
WHITE;GREEN CAPSULE · Hydroxyzine
2 manufacturers
EP136
GREEN CAPSULE · Hydroxyzine
31 manufacturers
H 105
WHITE ROUND · Hydroxyzine
16 manufacturers
H 106
WHITE ROUND · Hydroxyzine
34 manufacturers
H 107
WHITE ROUND · Hydroxyzine
17 manufacturers
HP 500
WHITE ROUND · Hydroxyzine
HP 501
WHITE ROUND · Hydroxyzine
3 manufacturers
HP 502
WHITE ROUND · Hydroxyzine
5 manufacturers
IG 275
WHITE ROUND · Hydroxyzine
IG 276
WHITE ROUND · Hydroxyzine
IG 277
WHITE ROUND · Hydroxyzine
3 manufacturers
IG 275
BROWN ROUND · Hydroxyzine
IG 276
BROWN ROUND · Hydroxyzine
3 manufacturers
IG 277
BROWN ROUND · Hydroxyzine
2 manufacturers
IX 657
GREEN CAPSULE · Hydroxyzine
14 manufacturers
IX 658
GREEN;WHITE CAPSULE · Hydroxyzine
3 manufacturers
K 10
WHITE ROUND · Hydroxyzine
9 manufacturers
K 11
WHITE ROUND · Hydroxyzine
15 manufacturers
K 12
WHITE ROUND · Hydroxyzine
17 manufacturers
K10
WHITE ROUND · Hydroxyzine
K11
WHITE ROUND · Hydroxyzine
3 manufacturers
K12
WHITE ROUND · Hydroxyzine
Side effects
The most frequently reported adverse reaction is "drowsiness," which the label states "is usually transitory and may disappear in a few days of continued therapy or on reduction of dose." Dry mouth from mild anticholinergic activity has also been reported. At higher-than-recommended doses, particularly in children, "involuntary motor activity, including tremor and convulsions," has occurred. Post-marketing reports include QT prolongation, Torsade de Pointes, headache, rash, urticaria, hallucination, and Acute Generalized Exanthematous Pustulosis (AGEP).